Search - tctmd.com

Displaying 301 - 320 of 481

Sort: Relevancy | Date

News Daily News

Better Outcomes, Fewer Complications Among Higher-Volume MitraClip Sites

Michael O'Riordan

July 17, 2019

News Conference News SCCT 2019

CTA or Function Tests in High-risk Chest Pain and No Known CAD: Debate Goes On

Yael L. Maxwell

July 16, 2019

News Daily News

FDA Grants Cardiac MR Indication for Gadavist Contrast Injection

Shelley Wood

July 16, 2019

News Industry News

FDA approves Bayer's Gadavist® (gadobutrol) injection as the first and only contrast agent for use in cardiac MR in adult patients with known or suspected coronary artery disease

July 15, 2019

Presentation SCCT 2019

Patients with High-risk of CAD But No Known CAD Should Go to CTA First Versus Functional Test First

Presenter: David Newby

July 11, 2019

Presentation SCCT 2019

Latest Insights From SCOT-HEART Sub-studies

Presenter: David Newby

July 11, 2019

News Daily News

Rapid-Access CT Model Seeks to Increase Efficiency, Reduce Delays for Chest Pain

Yael L. Maxwell

June 21, 2019

News Conference News SCAI 2019

FFR Changes Treatment Plan in More Than One-Third of All-Comer Patients

Yael L. Maxwell

June 04, 2019

News Conference News EuroPCR 2019

Off to EuroPCR 2019? Expect Mitral and Tricuspid Updates, Thin-Strut Stent Surprises, and ‘Strong’ Statements

Shelley Wood

May 16, 2019

News Features

Twitter Takes on the Times of India, but the Question Persists: Is Foregoing a Stent an Option?

Shelley Wood

April 30, 2019

News Industry News

Infraredx, a Nipro Company, Announces FDA Approval of Expanded Label Claim for the Makoto™ Intravascular Imaging System

April 22, 2019

Presentation ARCH 2019

Spontaneous Coronary Artery Dissection

Presenter: Alan C. Braverman

April 13, 2019

Presentation ARCH 2019

Imaging Cases

Presenter: Adam Shpigel

April 10, 2019

Presentation SIF 2019

Conversations in Cardiology

Presenter: Morton J. Kern

March 28, 2019

News Conference News ACC 2019

Info Gleaned From FFRCT Has Durable Impact on 1-Year Outcomes: ADVANCE Registry

Caitlin E. Cox

March 18, 2019

Presentation OPCI 2019

Show Me the Data: Evidence That Physiologic Lesion Assessment Improves Patient Outcomes

Presenter: Habib Samady

March 09, 2019

Presentation OPCI 2019

Optimal Duration of Antiplatelet Therapy – Does IV Imaging Make A Difference?

Presenter: Roxana Mehran

March 09, 2019

Presentation OPCI 2019

High Definition IVUS as a tool to optimize PCI

Presenter: Akiko Maehara

March 09, 2019

Presentation OPCI 2019

Basics of Coronary Physiology: FFR-Guided PCI in Stable CAD

Presenter: William F. Fearon

March 09, 2019

News Daily News

ISCHEMIA Patients: High Rates of Severe-to-Moderate Ischemia, Multivessel CAD

Michael O'Riordan

March 01, 2019

Advertisement

Better Outcomes, Fewer Complications Among Higher-Volume MitraClip Sites

CTA or Function Tests in High-risk Chest Pain and No Known CAD: Debate Goes On

FDA Grants Cardiac MR Indication for Gadavist Contrast Injection

FDA approves Bayer's Gadavist® (gadobutrol) injection as the first and only contrast agent for use in cardiac MR in adult patients with known or suspected coronary artery disease

Patients with High-risk of CAD But No Known CAD Should Go to CTA First Versus Functional Test First

Latest Insights From SCOT-HEART Sub-studies

Rapid-Access CT Model Seeks to Increase Efficiency, Reduce Delays for Chest Pain

FFR Changes Treatment Plan in More Than One-Third of All-Comer Patients

Off to EuroPCR 2019? Expect Mitral and Tricuspid Updates, Thin-Strut Stent Surprises, and ‘Strong’ Statements

Twitter Takes on the Times of India, but the Question Persists: Is Foregoing a Stent an Option?

Infraredx, a Nipro Company, Announces FDA Approval of Expanded Label Claim for the Makoto™ Intravascular Imaging System

Spontaneous Coronary Artery Dissection

Imaging Cases

Conversations in Cardiology

Info Gleaned From FFRCT Has Durable Impact on 1-Year Outcomes: ADVANCE Registry

Show Me the Data: Evidence That Physiologic Lesion Assessment Improves Patient Outcomes

Optimal Duration of Antiplatelet Therapy – Does IV Imaging Make A Difference?

High Definition IVUS as a tool to optimize PCI

Basics of Coronary Physiology: FFR-Guided PCI in Stable CAD

ISCHEMIA Patients: High Rates of Severe-to-Moderate Ischemia, Multivessel CAD

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content